Target Price | $263.59 |
Price | $231.96 |
Potential | 13.64% |
Number of Estimates | 22 |
22 Analysts have issued a price target JPMorgan Chase & Co. 2026 . The average JPMorgan Chase & Co. target price is $263.59. This is 13.64% higher than the current stock price. The highest price target is $330.00 42.27% , the lowest is $220.00 5.16% . | |
A rating was issued by 28 analysts: 16 Analysts recommend JPMorgan Chase & Co. to buy, 10 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the JPMorgan Chase & Co. stock has an average upside potential 2026 of 13.64% . Most analysts recommend the JPMorgan Chase & Co. stock at Purchase. |
15 Analysts have issued a sales forecast JPMorgan Chase & Co. 2025 . The average JPMorgan Chase & Co. sales estimate is $177b . This is 38.00% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $185b 35.01% , the lowest is $172b 39.54% .
This results in the following potential growth metrics:
2024 | $282b | 16.71% |
---|---|---|
2025 | $177b | 37.28% |
2026 | $181b | 2.68% |
2027 | $187b | 2.94% |
24 JPMorgan Chase & Co. Analysts have issued a net profit forecast 2025. The average JPMorgan Chase & Co. net profit estimate is $51.4b . This is 9.22% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $61.0b 7.81% , the lowest is $48.3b 14.71% .
This results in the following potential growth metrics and future Net Margins:
2024 | $54.9b | 21.69% |
---|---|---|
2025 | $51.4b | 6.37% |
2026 | $54.5b | 6.08% |
2027 | $59.1b | 8.38% |
2024 | 19.48% | 4.27% |
---|---|---|
2025 | 29.08% | 49.31% |
2026 | 30.04% | 3.30% |
2027 | 31.62% | 5.26% |
24 Analysts have issued a JPMorgan Chase & Co. forecast for earnings per share. The average JPMorgan Chase & Co. EPS is $18.49 . This is 9.23% lower than earnings per share in the financial year 2024. The highest EPS forecast is $21.96 7.81% , the lowest is $17.37 14.73% .
This results in the following potential growth metrics and future valuations:
2024 | $19.75 | 21.69% |
---|---|---|
2025 | $18.49 | 6.38% |
2026 | $19.62 | 6.11% |
2027 | $21.26 | 8.36% |
Current | 11.39 | 1.06% |
---|---|---|
2025 | 12.54 | 10.10% |
2026 | 11.83 | 5.66% |
2027 | 10.91 | 7.78% |
Based on analysts' sales estimates for 2025, the JPMorgan Chase & Co. stock is valued at an EV/Sales of 9.33 and an P/S ratio of 3.65 .
This results in the following potential growth metrics and future valuations:
Current | 5.78 | 12.23% |
---|---|---|
2025 | 9.33 | 61.39% |
2026 | 9.08 | 2.61% |
2027 | 8.82 | 2.86% |
Current | 2.26 | 8.63% |
---|---|---|
2025 | 3.65 | 61.30% |
2026 | 3.56 | 2.61% |
2027 | 3.46 | 2.86% |
JPMorgan Chase & Co....
Analyst | Rating | Action | Date |
---|---|---|---|
UBS |
Buy
➜
Buy
|
Unchanged | Apr 17 2025 |
Truist Securities |
Hold
➜
Hold
|
Unchanged | Apr 14 2025 |
Truist Securities |
Hold
➜
Hold
|
Unchanged | Apr 04 2025 |
B of A Securities |
Buy
➜
Buy
|
Unchanged | Apr 02 2025 |
Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Apr 01 2025 |
Keefe, Bruyette & Woods |
Market Perform
➜
Market Perform
|
Unchanged | Jan 16 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Jan 16 2025 |
Analyst Rating | Date |
---|---|
Unchanged
UBS:
Buy
➜
Buy
|
Apr 17 2025 |
Unchanged
Truist Securities:
Hold
➜
Hold
|
Apr 14 2025 |
Unchanged
Truist Securities:
Hold
➜
Hold
|
Apr 04 2025 |
Unchanged
B of A Securities:
Buy
➜
Buy
|
Apr 02 2025 |
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Apr 01 2025 |
Unchanged
Keefe, Bruyette & Woods:
Market Perform
➜
Market Perform
|
Jan 16 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jan 16 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.